We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Results from the REALITY trial presented at the American College of Cardiology
Annual Scientific Session found that Cordis' Cypher Sirolimus-eluting Coronary
Stent was associated with development of significantly fewer blood clots at
the stent site (stent thromboses) than the Boston Scientific/Angiotech Taxus
Paclitaxel-eluting Coronary Stent.
Conor Medsystems presented angiographic and clinical data from the company's
pivotal EuroSTAR study evaluating its CoStar cobalt chromium paclitaxel-eluting
stent in a complex patient cohort.
William Wijns, the co-principal investigator of the Endeavor II pivotal clinical
trial and co-director of the Cardiovascular Center, OLV Ziekenhuis, Aalst, Belgium,
presented positive results of the Endeavor II trial at the American College
of Cardiology 54th Annual Scientific Session.
IRIS International, a manufacturer and marketer of
automated IVD urinalysis systems and medical devices used in hospitals and reference
clinical laboratories worldwide, has announced the launch and first shipment
of its iQ200 Sprint, the fastest automated urine microscopy analyzer on the
market.
Images, a provider of enterprise-wide advanced visualization software,
is introducing ViTALCardia, a technology solution designed specifically for
cardiologists. ViTALCardia includes high-powered software for diagnosis as well
as a Web-based thin-client distribution technology to provide access to images
throughout the cardiology enterprise.
Matritech, a developer of proteomics-based diagnostic products, has entered
into an agreement providing for a $12.55 million private placement for the sale
of 1,426,124 shares of its Series A Convertible Preferred Stock, each share
of which is convertible into 10 shares of common stock, and five-year warrants
to purchase 4,991,382 shares of common stock at an exercise price of $1.47 per
share.
Biotechnology company Chiron said that it settled a suit against a licenser
of cystic fibrosis products that will require the company, SourceCF, to attach
a warning label on promotional materials for an electronic inhaler.
ReGen Biologics, an orthopedic products company that develops, manufactures
and markets innovative products for human tissue repair in the U.S. and abroad,
has announced that the company has regained its rights to exclusively market
and distribute its patented Collagen Meniscus Implant throughout the world.
Boston Scientific has completed its acquisition of Advanced Stent Technologies
(AST) of Pleasanton, Calif., for an initial payment of $120 million payable
in Boston Scientific stock, plus the possibility of future contingent payments.
Vascular Solutions has received notification from the Japanese Ministry of Health,
Labor and Welfare of regulatory approval for the Pronto extraction catheter.